Latest Share Chat

REMOVE ADS

Avacta Group Share News (AVCT)

Avacta Group Information

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes

Get Live Data

71.00 -5.00 (-6.67%)

Bid:

70.00

Ask:

72.00

Spread: 2.00 (2.857%)

Market Cap: £318.58m

Last checked at -

Intraday Avacta Group Share Chart

REMOVE ADS

Avacta Group News

Avacta opens phase 1 trial for conjugate's efficacy regarding tumours

(Alliance News) - Avacta Group PLC on Monday announced the opening of a phase 1 trial for AVA6103, a peptide-drug conjugate.

Health Care

Avacta upbeat on preCISION comparative study

(Sharecast News) - Avacta Therapeutics said on Tuesday that new preclinical analysis indicated its proprietary 'preCISION' tumour-activated delivery p...

Market News

Avacta hails new data supporting proprietary preCision platform

(Alliance News) - Avacta Group PLC on Tuesday saw its shares rise, as it said new data demonstrates a favourable delivery profile and advantages of it...

Avacta finds new science chief internally

(Sharecast News) - Avacta Therapeutics announced the appointment of Francis Wilson as its chief scientific officer on Monday, effective immediately, a...

Avacta appoints new chief scientific officer, plans clinical trials

(Alliance News) - Avacta Group PLC on Monday said it has promoted Francis Wilson to chief scientific officer.

Avacta agrees two key clinical trial updates

(Sharecast News) - Avacta Therapeutics said on Tuesday that it had agreed two key clinical protocol updates to its faridoxorubicin, or AVA6000, progra...

CORRECT: Avacta reports progress in faridoxorubicin clinical programme

(Correcting that Avacta Group is headquartered in London).

Avacta reports progress in faridoxorubicin clinical programme

(Alliance News) - Avacta Group PLC on Tuesday saw its shares climb higher as it reported two clinical updates to its faridoxorubicin, or AVA6000, clin...